FibroGen

Roxadustat safety analysis provokes more questions than answers
EP Vantage
Fri, 05/10/19 - 10:29 am
FibroGen
roxadustar
anemia
AstraZeneca
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
Yahoo/Benzinga
Sun, 03/24/19 - 12:02 pm
FDA
Novartis
Ascendis
Eiger BioPharmaceuticals
Proteostasis Therapeutics
Fibrocell Science
Supernus Pharmaceuticals
FibroGen
INSYS Therapeutics
Upcoming events – Fibrogen and Alnylam look to broaden their horizons
EP Vantage
Sat, 03/2/19 - 12:44 pm
FibroGen
roxadustat
pamrevlumab
Duchenne Muscular Dystrophy
givosiran
Alnylam
Latest Phase 2 Data Shows Pamrevlumab Reduces Rate of Progression in Idiopathic Pulmonary Fibrosis
CP Wire
Tue, 05/22/18 - 11:11 am
FibroGen
pamrevlumab
IPF
idiopathic pulmonary fibrosis
Latest Phase 2 Data Shows Pamrevlumab Reduces Rate of Progression in Idiopathic Pulmonary Fibrosis
Mon, 05/21/18 - 10:44 pm
FibroGen
pamrevlumab
idiopathic pulmonary fibrosis
Galapagos spotlights an ‘exciting’ round of PoC data for IPF drug, shares surge
Endpoints
Thu, 08/10/17 - 11:53 am
Galapagos
IPF
GLPG1690
FibroGen
FibroGen Has The Look Of A Long-Term Biotech Winner
Seeking Alpha
Sun, 07/10/16 - 12:32 pm
FibroGen
roxadustat
kidney disease
9 Biotech Picks for 2016
Barron's
Sat, 01/2/16 - 10:19 am
biotech
Adaptimmune
Dermira
FibroGen
Incyte
Intra-Cellular Therapies
Seres Therapeutics
Ophthotech
Neurocrine Biosciences
Paratek
IPO Stock Watch: FibroGen Up With Liver-Disease Field
Investors.com
Tue, 01/6/15 - 08:41 am
IPOs
FibroGen
liver disease
NASH
Show me the money: Which drugs made the top 10 list on upfront deals?
Fierce Biotech
Mon, 05/12/14 - 09:36 am
biotech
GED-0301
Celgene
Nogra Pharma
AbbVie
Reata
Bardoxolone
Abbott Labs
Tradjenta
Eli Lilly
Boehringer Ingelheim
FG-4592
AstraZeneca
FibroGen
Pfizer
Bristol-Myers Squibb
Eliquis
Moderna
Forma Therapeutics
dimebon
Medivation
Jakafi
Novartis
Incyte
FierceBiotech's 2013 Fierce 15
Fierce Biotech
Wed, 09/25/13 - 01:04 pm
biotech
AnaptysBio
Acetylon Pharmaceuticals
CytomX
Immunocore
FibroGen
Jounce Therapeutics
Kala Pharmaceuticals
Macrogenics
Moderna Therapeutics
Presage Biosciences
Nimbus Discovery
Scioderm
Ultragenyx
uniQure
Visterra
Astellas, GSK vie to make 'high altitude' anemia pill
Reuters
Fri, 04/19/13 - 08:52 am
Astellas
GSK
anemia
GSK 1278863
FibroGen
FG-4592
FibroGen: Drug could reduce lung fibrosis
Bizjournals.com
Tue, 05/18/10 - 09:54 am
FibroGen
IPF
FibroGen initiates trial of cancer drug
Bizjournals.com
Tue, 12/16/08 - 07:20 am
FibroGen
cancer

Pages